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Objective: Non myeloablative conditioning regimen 
(NMCR) for AHSCT have been developed to reduce 
procedure-related toxicity. The aim of this approache is 
to extend indications of AHSCT to patients (pts) who 
are not eligible previously for high dose chemotherapy 
or total body irradiation. We describe infectious mor- 
bidity related to this new procedure in our unit in a 
retrospective study. 
Results: 45 AHSCT with NMCR were performed in our 
unit between 1997 to 2001,32 males, 13 females, with a 
median age of 48 years (range 18-62). Hematologic 
diagnosis were 8 AL, 12 MM, 2 CML, 5 NHL, 3 MDS, 6 
Hodgkin diseases, 3 CLL, 6 solid tumors. Engraftment 
was observed in all pts with a median of 21 days (range 
12119) for PNN >0.5 g/l, and 18 days (range O-201) for 
platelets >50 g/l. Ten pts received donor lymphocyte 
infusions (DLI). Nineteen pts (48.7%) presented acute 
GVHD: 7 without any DLI, 4 before DLI and 8 after 
DLI (2 grade 1,7 grade 2,4 grade 3 and 2 grade 4). 
Nineteen pts (42%) presented 39 infections : 1 episode, 
II = 7; 2 episodes, II = 7; 3 episodes, it = 3; 4 episodes, n= 1; 
5 episodes, y1= 1. Twenty two infections (56.5 %) occured 
in 13 pts during 3 months post transplant : 18 septi- 
cemia (12 Gram-negative bacilli, 5 Gram-positive cocci, 
one yeast), 1 septic chock without documentation, 2 
cytomegalovirus (CMV) infections, 1 zoster. Only 4 of 
these infections occured after engraftment (3 bacterial 
septicemia and 1 CMV disease). The pt with fungal 
septicemia died before engraftment. We observed 17 late 
infections (43.5%) in 11 pts : 3 septicemia, 1 septic chock 
without documentation, 2 CMV diseases, 6 probable 
invasive aspergillosis, 1 zoster, 1 Campylobacter colitis, 
1 Staphylococcus aureus pneumonia, 1 EBV lymphoma 
and 1 enterovirus encephalitis. Overall, bacterial in- 
fections were observed in 56% of cases, viral in 20% and 
fungal in 18%. No infection occured in 26 pts (58%). 
Five pts with hematologic malignancy relapse pre- 
sented a probable invasive aspergillosis. 
Twenty eight pts died (62%) 16 in relapse, 9 (32%) 
with infection : 1 fungal septicemia, 1 viral encephalitis, 
1 hepatitis, 6 invasive aspergillosis. 
Conclusion: Most of infections observed after AHSCT 
with NMCR were bacterial in our experience. 
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Aim: To describe the results of our strategies of pre- 
vention and treatment of infectious episodes during the 
neutropenic phase in HSCT Rc. 
Materials and methods : Total number of HSCT 417; 
number of patients (pts): 388; mean age: 33.9 (l-70); 
female: 256 (61%); hematological diseases: 247 (59%) 
solid tumors: 168 (40%) others 2; autologous (AU) 
314 (75%) allogeneic (AL) 103 (25%): related 89 (85%, 
haploidentical 3-2%) non-related 14 (13%): bone 
marrow 10, umbilical cord blood 4. Mean engraftment 
days: 12.8 (0-48).Weekly surveillance cultures (WSC) 
were done: anterior nares swab: detection (dt) of 
methicillin-resistant (R) Staphylococcus sp, penicillin-R 
pneumococci and Aspergillus sp, mouthwash: dt of 
Candida sp, penicillin-R Streptococcus sp and stool: dt 
of multidrug-R aerobic gram-negative bacilli (AGNB), 
vancomycin-R Enterococcus and Candida sp. Routinely 
selective gastrointestinal decontamination for AGNB 
and antifungal prophylaxis were not done. Fluconazol 
(FLU) was used only in pts with non-C. krusei colon- 
ization detected by WSC. The initial empirical treatment 
for neutropenia and fever was ceftazidime plus amikacin. 
The febrile episodes were defined according to the guide- 
lines of the Immunocompromised Host Society (1990). 
Results: 434 febrile episodes were detected: a) microbio- 
logically defined infection 150 (34.5%): mono or poly- 
microbial bacteremia (B) 63, fungemia (F) 2; site of 
infection (SI) with B 37 and with F 3; bacterial SI without 
B 55 and fungal SI without F 6; b) clinically defined 
infection 90 (21%) and c) possible infection 194 (45 %); 
there were 11 pts without fever. Isolated micro- 
organisms: 121 from 105 B and F,AGNB 52 (43%) with 
46 (85%) Enterobacteriaceae, gram-positive cocci 53 
(44%) with 41(77%) Staphylococcus sp, others 11(9%) 
and non-C. albicans 5 (4%). Nine pts had polymicrobial 
B and 7 more than one episode of B. The most frequent 
sites of infections with or without microbiological docu- 
mentation were: urinary tract 51(25%), lungs 48 (23%) 
skin and soft tissues 31 (15%) anal 25 (12%) and 
catheter 21 (lO%).Two hundred thirty colonized pts 
(55%) received FLU prophylaxis and 136 pts (33%) 
empirical amphotericin B (desoxycholate 119, liposomal 
28). Related transplant mortality was 10% (38/388), 
AU 8% (25/314), Al 13% (13003)and associated with 
documented infection 2% (7/388). 
Conclusions: (1) The use of FLU was avoided in 45 % of 
the pts, with the benefit of decreasing toxicity and costs. 
(2) All fungemias were by non-C.albicans, probably due 
to the previous overuse of FLU. (3) The same empirical 
antibiotic treatment has been used from the beginning 
of the program without emergence of R strains. (4) 
Mortality associated to documented infection was low, 
supporting our strategies of prevention and treatment. 
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Background: Transmission of bacterial infections from a 
donor to multiple recipients may occur in the setting of 
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donor bacteremia. We describe a novel mechanism for 
transmission through direct contamination of a thoracic 
vascular graft that was removed at the time of organ 
retrieval. The use of a contaminated innominate artery 
jump graft for pancreas transplantation resulted in 
vascular anastomotic infection in multiple recipients 
from a non-bacteremic donor colonized with Pseudo- 
monas aeruginosa. 
Methods: Patient data was collected by chart review 
from the donor and the kidney, kidney-pancreas, heart, 
lung and liver recipients at 4 separate transplant centers. 
Isolates of P aeruginosa were tested for relatedness by 
molecular typing using pulsed-field gel electrophoresis 
(PFGE). 
Results: The donor was a previously healthy 25 year old 
man who died of a closed head injury. He was intubated 
for 24h prior to organ retrieval. The donor’s routine 
tracheal suction cultures were positive for P aeruginosa 
but all blood cultures were negative. Organs were 
retrieved for lung, liver, kidney-pancreas, kidney, and 
heart transplantation. The donor trachea was transected 
and the intrathoracic organs were removed first. A 
second transplant team retrieved the innominate artery 
graft, which was in close proximity to the open end of 
the donor trachea, and the intra-abdominal organs. The 
kidney-pancreas recipient had Pseudomonas bacteremia 
and rupture of the anastomosis between the innominate 
artery and native iliac artery 48h post-transplant; the 
pancreas was subsequently lost. The renal transplant 
recipient lost his graft from a renal artery anastomotic 
rupture 9 days after transplant. The liver transplant 
recipient died from a ruptured mycotic aneurysm of the 
hepatic artery associated with P aeruginosa bacteremia. 
The lung transplant recipient developed P aeruginosa 
pneumonia but no endovascular infection. The heart 
recipient had an uncomplicated post-operative course. 
All 5 Pseudomonas isolates had the same antibiogram 
and were found to be identical by molecular typing using 
PFGE. 
Conclusion: We conclude that donors may transmit 
bacterial infections to multiple recipients by mech- 
anisms other than donor bacteremia. This highlights the 
importance of obtaining donor cultures from multiple 
sites. In this outbreak, the spillage of tracheal secretions 
from the transected trachea directly contaminated the 
innominate artery graft, which resulted in cross- 
contamination of the intraabdominal organs. Although 
donor tracheal cultures are commonly positive, careful 
consideration should be given to antimicrobial treat- 
ment of recipients when a Gram-negative organism is 
isolated. 
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Aim: To evaluate our strategy of FLU P only in HSCT 
R with non-Candida krusei colonization (COL). 
Materials and Methods: A prospective cohort study 
from July 1996 to December 2001; 289 consecutive 
HSCT R were included to detect Candida spp from oro- 
pharynx and stool (high risk pts) by weekly surveillance 
cultures, taken from the beginning of chemotherapy 
until neutropenia was resolved and were plated onto 
selective Chrom-agar plates. Only the pts with non- 
Ckrusei COL received FLU 200 mg/day until engraft- 
ment or empirical amphotericin B initiation; pts under- 
going antifungal prophylaxis or treatment at the time of 
inclusion were excluded. Demographic characteristics 
were: n pts: 289, mean age: 33.8 (O-70) female: 169 
(58%), hematological diseases: 197 (68%), solid tumors: 
89 (32%) others: 3 (1%) autologous (AU): 203 (70%) 
allogeneic (AL): 86 (30%) mean engraftment days: 12.8 
(3-48). 
Results: There were no differences in the frequency of 
MD IF1 in the compared populations 
l C albicans was the most frequent species isolated in 
COL pts and caused 2 IF1 
l Candida krusei was isolated in 6 (3.4%) COL pts, 3 
selected during FLU P 
l Two Ckrusei caused 2 (1.4%) IF1 and were isolated 
after 9 and 14 days of FLU P 
l There was one mortality related to MD IF1 
Conclusions: (1) There were significantly more 
neutropenia days and empirical amphotericin B usage in 
COL population. (2) FLU P only in non-Candida krusei 
COL pts was safe and cost-effective, avoiding toxicity 
and emergence of resistant strains. 
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We performed a survey to elicit risk factors for CMV 
retinitis (CMVR) after blood stem cell transplantation 
(SCT). A total of 24 cases have been reported from 13 
EBMT centres. In the risk factor analysis, 18 patients 
were included. A control group of 2467 patients was 
selected who were transplanted at the contributing 
centres during the study period who had a follow up 
time of more than one month. The median time from 
transplantation to diagnosis of CMVR was 160 days 
